Connor Clark & Lunn Investment Management Ltd. lessened its position in Angi Inc. (NASDAQ:ANGI – Free Report) by 8.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 411,424 shares of the technology company’s stock after selling 37,594 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.08% of Angi worth $1,061,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of ANGI. Headlands Technologies LLC bought a new position in Angi in the second quarter valued at approximately $26,000. Susquehanna Fundamental Investments LLC bought a new position in Angi in the second quarter valued at approximately $85,000. Assenagon Asset Management S.A. bought a new position in Angi in the second quarter valued at approximately $183,000. Quadrature Capital Ltd grew its stake in Angi by 21.4% in the first quarter. Quadrature Capital Ltd now owns 96,857 shares of the technology company’s stock valued at $256,000 after purchasing an additional 17,102 shares in the last quarter. Finally, Cowen AND Company LLC bought a new position in Angi in the second quarter valued at approximately $267,000. Institutional investors and hedge funds own 12.84% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have weighed in on ANGI shares. UBS Group upgraded Angi to a “hold” rating in a research note on Monday, October 28th. The Goldman Sachs Group downgraded Angi from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $3.25 to $2.50 in a research note on Wednesday, November 13th. Benchmark reduced their target price on Angi from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Citigroup downgraded Angi from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $3.25 to $2.00 in a research note on Wednesday, November 13th. Finally, KeyCorp reduced their target price on Angi from $3.00 to $2.00 and set an “overweight” rating for the company in a research note on Wednesday, November 20th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $3.11.
Angi Stock Performance
ANGI opened at $1.90 on Thursday. The business has a fifty day simple moving average of $2.40 and a 200 day simple moving average of $2.30. The company has a market capitalization of $944.81 million, a PE ratio of 27.00 and a beta of 1.95. Angi Inc. has a 1 year low of $1.65 and a 1 year high of $3.10. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.05 and a quick ratio of 2.05.
Angi (NASDAQ:ANGI – Get Free Report) last released its quarterly earnings results on Monday, November 11th. The technology company reported $0.07 earnings per share (EPS) for the quarter. The business had revenue of $296.72 million during the quarter, compared to the consensus estimate of $295.90 million. Angi had a return on equity of 3.79% and a net margin of 2.61%. During the same period in the previous year, the company posted ($0.01) EPS. Research analysts expect that Angi Inc. will post 0.04 EPS for the current year.
Angi Company Profile
Angi Inc connects home service professionals with consumers in the United States and internationally. The company operates through three segments: Ads and Leads, Services, and International. It provides consumers with tools and resources to help them find local, pre-screened and customer-rated service professionals, matches consumers with independently established home services professionals.
Featured Articles
- Five stocks we like better than Angi
- Best Aerospace Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Buy Cheap Stocks Step by Step
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Angi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Angi and related companies with MarketBeat.com's FREE daily email newsletter.